WO2013060067A1 - 膜式渗透汽化式固定人工生物瓣的方法及装置 - Google Patents
膜式渗透汽化式固定人工生物瓣的方法及装置 Download PDFInfo
- Publication number
- WO2013060067A1 WO2013060067A1 PCT/CN2011/084056 CN2011084056W WO2013060067A1 WO 2013060067 A1 WO2013060067 A1 WO 2013060067A1 CN 2011084056 W CN2011084056 W CN 2011084056W WO 2013060067 A1 WO2013060067 A1 WO 2013060067A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reaction chamber
- pervaporation
- reaction
- fixed
- membrane
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 46
- 238000005373 pervaporation Methods 0.000 title claims abstract description 43
- 238000006243 chemical reaction Methods 0.000 claims abstract description 83
- 239000007788 liquid Substances 0.000 claims abstract description 37
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 10
- 239000012466 permeate Substances 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims description 43
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 26
- 239000012295 chemical reaction liquid Substances 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 230000008016 vaporization Effects 0.000 claims description 6
- 238000009834 vaporization Methods 0.000 claims description 5
- 239000012510 hollow fiber Substances 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 abstract 2
- 239000000376 reactant Substances 0.000 abstract 2
- 210000004379 membrane Anatomy 0.000 description 38
- 239000000126 substance Substances 0.000 description 11
- 238000007385 chemical modification Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000000835 fiber Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/36—Pervaporation; Membrane distillation; Liquid permeation
- B01D61/362—Pervaporation
- B01D61/3621—Pervaporation comprising multiple pervaporation steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/36—Pervaporation; Membrane distillation; Liquid permeation
- B01D61/362—Pervaporation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Water Supply & Treatment (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Manufacturing & Machinery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Prostheses (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011379710A AU2011379710B2 (en) | 2011-10-27 | 2011-12-15 | Method and device for fixing artificial bioprosthetic valve by membrane pervaporation |
IN900KON2014 IN2014KN00900A (zh) | 2011-10-27 | 2011-12-15 | |
BR112014009974-0A BR112014009974B1 (pt) | 2011-10-27 | 2011-12-15 | dispositivo e método para fixação de uma válvula artificial de bioprótese por pervaporação através de membrana |
EP11874705.4A EP2772227B1 (en) | 2011-10-27 | 2011-12-15 | Method and device for fixing artificial bioprosthetic valve by membrane pervaporation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110332309.7 | 2011-10-27 | ||
CN201110332309.7A CN102423505B (zh) | 2011-10-27 | 2011-10-27 | 膜式渗透汽化式固定人工生物瓣的方法及装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013060067A1 true WO2013060067A1 (zh) | 2013-05-02 |
Family
ID=45957589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2011/084056 WO2013060067A1 (zh) | 2011-10-27 | 2011-12-15 | 膜式渗透汽化式固定人工生物瓣的方法及装置 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2772227B1 (zh) |
CN (1) | CN102423505B (zh) |
AU (1) | AU2011379710B2 (zh) |
BR (1) | BR112014009974B1 (zh) |
IN (1) | IN2014KN00900A (zh) |
WO (1) | WO2013060067A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
CN113633435A (zh) | 2016-01-29 | 2021-11-12 | 内奥瓦斯克迪亚拉公司 | 用于防止流出阻塞的假体瓣膜 |
CN113893064A (zh) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11602429B2 (en) | 2019-04-01 | 2023-03-14 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
WO2020210652A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
CA3140925A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
CN111701078B (zh) * | 2020-04-20 | 2022-08-19 | 上海以心医疗器械有限公司 | 一种提高生物组织交联度的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN201244101Y (zh) * | 2008-07-03 | 2009-05-27 | 中国人民解放军第四军医大学 | 脉动生物反应器 |
US20100022677A1 (en) * | 2008-07-24 | 2010-01-28 | Zimmer, Inc. | Reduction of free radicals in crosslinked polyethylene by infrared heating |
US20100196870A1 (en) * | 2000-06-01 | 2010-08-05 | Crosscart, Inc. | Sterilized xenograft tissue |
CN102172338A (zh) * | 2011-02-28 | 2011-09-07 | 微创医疗器械(上海)有限公司 | 梯度浸没式化学改性人工生物瓣的装置 |
CN102178571A (zh) * | 2011-03-28 | 2011-09-14 | 微创医疗器械(上海)有限公司 | 利用声波测量人工生物瓣膜改性程度的装置及方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4800603A (en) * | 1987-01-30 | 1989-01-31 | Jaffe Norman R | Tissue fixation with vapor |
US5931969A (en) * | 1994-07-29 | 1999-08-03 | Baxter International Inc. | Methods and apparatuses for treating biological tissue to mitigate calcification |
US7045062B1 (en) * | 2003-01-21 | 2006-05-16 | Seventy-Seventh Meridian Corporation, Llc | Pervaporation membranes and methods of use |
EP1693025A1 (en) * | 2005-02-17 | 2006-08-23 | Universität Zürich | Method of manufacturing a tissue-engineered prosthesis |
CN101665564B (zh) * | 2009-09-24 | 2011-09-14 | 同济大学 | 膜式脱水型乳酸缩聚反应装置 |
CN101947147A (zh) * | 2010-06-23 | 2011-01-19 | 乐普(北京)医疗器械股份有限公司 | 一种生物组织材料的化学处理方法 |
-
2011
- 2011-10-27 CN CN201110332309.7A patent/CN102423505B/zh active Active
- 2011-12-15 IN IN900KON2014 patent/IN2014KN00900A/en unknown
- 2011-12-15 EP EP11874705.4A patent/EP2772227B1/en active Active
- 2011-12-15 AU AU2011379710A patent/AU2011379710B2/en active Active
- 2011-12-15 WO PCT/CN2011/084056 patent/WO2013060067A1/zh active Application Filing
- 2011-12-15 BR BR112014009974-0A patent/BR112014009974B1/pt active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100196870A1 (en) * | 2000-06-01 | 2010-08-05 | Crosscart, Inc. | Sterilized xenograft tissue |
CN201244101Y (zh) * | 2008-07-03 | 2009-05-27 | 中国人民解放军第四军医大学 | 脉动生物反应器 |
US20100022677A1 (en) * | 2008-07-24 | 2010-01-28 | Zimmer, Inc. | Reduction of free radicals in crosslinked polyethylene by infrared heating |
CN102172338A (zh) * | 2011-02-28 | 2011-09-07 | 微创医疗器械(上海)有限公司 | 梯度浸没式化学改性人工生物瓣的装置 |
CN102178571A (zh) * | 2011-03-28 | 2011-09-14 | 微创医疗器械(上海)有限公司 | 利用声波测量人工生物瓣膜改性程度的装置及方法 |
Non-Patent Citations (3)
Title |
---|
CHEUL LEE; SOO HWAN KIM; SEUNG-HWA CHOI; YONG JIN KIM ET AL.: "High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect", EUR J CARDIOTHORAC SURG, vol. 39, 2011, pages 381 - 387 |
JAMES D. OLSON: "The vapor pressure of pure and aqueous glutaraldehyde", FLUID PHASE EQUILIBRIA, vol. 150-151, 1998, pages 713 - 720 |
See also references of EP2772227A4 |
Also Published As
Publication number | Publication date |
---|---|
AU2011379710B2 (en) | 2015-09-03 |
CN102423505B (zh) | 2014-12-10 |
EP2772227A1 (en) | 2014-09-03 |
AU2011379710A1 (en) | 2014-05-15 |
EP2772227A4 (en) | 2015-04-15 |
IN2014KN00900A (zh) | 2015-10-09 |
CN102423505A (zh) | 2012-04-25 |
EP2772227B1 (en) | 2017-09-06 |
BR112014009974B1 (pt) | 2020-11-10 |
BR112014009974A2 (pt) | 2017-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013060067A1 (zh) | 膜式渗透汽化式固定人工生物瓣的方法及装置 | |
Yang et al. | Surface modification of polypropylene microporous membranes with a novel glycopolymer | |
Liu et al. | Pervaporation membranes for biobutanol production | |
CN109939571B (zh) | 一种氧化石墨烯框架复合膜及其制备方法和应用 | |
WO2010114010A1 (ja) | 有機蒸気分離用の中空糸エレメント | |
Bhanthumnavin et al. | Surface modification of bacterial cellulose membrane by oxygen plasma treatment | |
Kimmel et al. | Carbonic anhydrase immobilized on hollow fiber membranes using glutaraldehyde activated chitosan for artificial lung applications | |
CN109224889A (zh) | 一种具有抗凝性能的血液净化膜及其制备方法 | |
CN110124541A (zh) | 一种喹诺酮信号分子抑制剂改性的抗生物污染复合膜及其制备方法 | |
CN105833738B (zh) | 纳米纤维素/大豆蛋白复合过滤材料及制备方法、用途 | |
CN107915862B (zh) | 一种用于油水分离的纸纤维调控孔径的海绵的制备方法 | |
Ashraf et al. | Fabrication and dialysis performance of functionalized multiwall carbon nanotubes integrated cellulose acetate/poly (vinylpyrrolidone) membranes | |
Zhu et al. | Biomimetic sulfated silk nanofibrils for constructing rapid mid-molecule toxins removal nanochannels | |
CN112423867A (zh) | 包含碳酸酐酶的二氧化碳分离膜 | |
CN101507904B (zh) | 一种复合超滤膜及其制备方法 | |
CN111804162A (zh) | 一种高通量聚四氟乙烯复合纳滤膜的制备方法 | |
JP4235822B2 (ja) | 分離膜を用いた発酵エタノールの濃縮方法 | |
CN112973472B (zh) | 一种薄层复合膜的功能化方法 | |
US20030034304A1 (en) | N-acetylated chitosan membranes | |
JP2011083750A (ja) | 分離膜による水の分離方法 | |
JP4045342B2 (ja) | 発酵エタノールの膜分離方法 | |
CN110975637A (zh) | 一种没食子酸-壳聚糖/聚砜复合纳滤膜的制备方法 | |
CN110280146B (zh) | 一种三维网状有机柔性材料修复分子筛膜缺陷的方法 | |
US20130184452A1 (en) | Waterless degumming system | |
Farahi et al. | Surface improvement and modification of PDMS. SiO2/PES membrane for ethanol/water separation in membrane bioreactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11874705 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2011874705 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011874705 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011379710 Country of ref document: AU Date of ref document: 20111215 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014009974 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014009974 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140425 |